Altogether, these results indicate that increased immunosuppressive T cells and decreased monocytes & DCs are associated with higher levels of NOS1 & DNMT1 and lower level of CCL5 in the NB high-risk group, and TGX221 is a potential agent in inhibiting the oncogenic and glucose-dysregulated pathway. This evidence concerns the gene DNMT1 and neuroblastoma.